Sector
Clinical Trials Tech
Discover the early-stage Clinical Trials Tech ecosystem: investors, accelerators, incubators, fellowships, grants, and global hubs powering next-gen Clinical Trials Tech startups.
Discover the early-stage Clinical Trials Tech ecosystem: investors, accelerators, incubators, fellowships, grants, and global hubs powering next-gen Clinical Trials Tech startups.
Scouts
Share promising startups in this sector and get rewarded if they raise. No prior track record needed.
Investors
Access qualified startups curated by Superscout across pre-seed to seed.
Supporters
Work at a company, lab, or city? Connect with builders in your space.
Clinical trials technology, a child sector within Superscout's Healthcare category, encompasses the platforms that modernize the design, recruitment, management, and analysis of clinical research studies, including decentralized clinical trial platforms, patient recruitment tools, electronic data capture, clinical trial management systems, and AI-powered trial design optimization. With 3 funders actively investing in clinical trials tech startups tracked in Superscout's database, the sector addresses the pharmaceutical industry's most expensive and time-consuming bottleneck.
The clinical trials tech investment thesis is driven by the staggering inefficiency of clinical research: the average Phase III trial costs $150-200 million, takes 3-5 years, and 80% of trials fail to meet enrollment timelines. Technology that accelerates patient recruitment, enables remote monitoring (decentralized trials), optimizes trial design using historical data, and automates regulatory compliance can save pharmaceutical companies hundreds of millions per program.
For clinical trials tech founders, the 2025-2026 funding environment rewards companies with validated deployments at pharmaceutical companies or CROs, demonstrated improvements in recruitment speed or trial efficiency, and the regulatory expertise needed to operate in the heavily regulated clinical research environment.
